| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.009 |